Dawn Gano1, Mai-Lan Ho2, John Colin Partridge3, Hannah C Glass4, Duan Xu5, A James Barkovich6, Donna M Ferriero7. 1. Department of Neurology, University of California, San Francisco, San Francisco, CA; Department of Pediatrics, University of California, San Francisco, San Francisco, CA. Electronic address: Dawn.Gano@ucsf.edu. 2. Department of Radiology, Mayo Clinic, Rochester, MN. 3. Department of Pediatrics, University of California, San Francisco, San Francisco, CA. 4. Department of Neurology, University of California, San Francisco, San Francisco, CA; Department of Pediatrics, University of California, San Francisco, San Francisco, CA; Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA. 5. Department of Radiology, University of California, San Francisco, San Francisco, CA. 6. Department of Neurology, University of California, San Francisco, San Francisco, CA; Department of Pediatrics, University of California, San Francisco, San Francisco, CA; Department of Radiology, University of California, San Francisco, San Francisco, CA. 7. Department of Neurology, University of California, San Francisco, San Francisco, CA; Department of Pediatrics, University of California, San Francisco, San Francisco, CA.
Abstract
OBJECTIVE: To determine the association of antenatal magnesium sulfate with cerebellar hemorrhage in a prospective cohort of premature newborns evaluated by magnetic resonance imaging (MRI). STUDY DESIGN: Cross-sectional analysis of baseline characteristics from a prospective cohort of preterm newborns (<33 weeks gestation) evaluated with 3T-MRI shortly after birth. Exclusion criteria were clinical evidence of a congenital syndrome, congenital infection, or clinical status too unstable for transport to MRI. Antenatal magnesium sulfate exposure was abstracted from the medical records and the indication was classified as obstetric or neuroprotection. Two pediatric neuroradiologists, blinded to the clinical history, scored axial T2-weighted and iron susceptibility MRI sequences for cerebellar hemorrhage. The association of antenatal magnesium sulfate with cerebellar hemorrhage was evaluated using multivariable logistic regression, adjusting for postmenstrual age at MRI and known predictors of cerebellar hemorrhage. RESULTS: Cerebellar hemorrhage was present in 27 of 73 newborns (37%) imaged at a mean ± SD postmenstrual age of 32.4 ± 2 weeks. Antenatal magnesium sulfate exposure was associated with a significantly reduced risk of cerebellar hemorrhage. Adjusting for postmenstrual age at MRI, and predictors of cerebellar hemorrhage, antenatal magnesium sulfate was independently associated in our cohort with decreased cerebellar hemorrhage (OR, 0.18; 95% CI, 0.049-0.65; P = .009). CONCLUSION: Antenatal magnesium sulfate exposure is independently associated with a decreased risk of MRI-detected cerebellar hemorrhage in premature newborns, which could explain some of the reported neuroprotective effects of magnesium sulfate.
OBJECTIVE: To determine the association of antenatal magnesium sulfate with cerebellar hemorrhage in a prospective cohort of premature newborns evaluated by magnetic resonance imaging (MRI). STUDY DESIGN: Cross-sectional analysis of baseline characteristics from a prospective cohort of preterm newborns (<33 weeks gestation) evaluated with 3T-MRI shortly after birth. Exclusion criteria were clinical evidence of a congenital syndrome, congenital infection, or clinical status too unstable for transport to MRI. Antenatal magnesium sulfate exposure was abstracted from the medical records and the indication was classified as obstetric or neuroprotection. Two pediatric neuroradiologists, blinded to the clinical history, scored axial T2-weighted and iron susceptibility MRI sequences for cerebellar hemorrhage. The association of antenatal magnesium sulfate with cerebellar hemorrhage was evaluated using multivariable logistic regression, adjusting for postmenstrual age at MRI and known predictors of cerebellar hemorrhage. RESULTS:Cerebellar hemorrhage was present in 27 of 73 newborns (37%) imaged at a mean ± SD postmenstrual age of 32.4 ± 2 weeks. Antenatal magnesium sulfate exposure was associated with a significantly reduced risk of cerebellar hemorrhage. Adjusting for postmenstrual age at MRI, and predictors of cerebellar hemorrhage, antenatal magnesium sulfate was independently associated in our cohort with decreased cerebellar hemorrhage (OR, 0.18; 95% CI, 0.049-0.65; P = .009). CONCLUSION: Antenatal magnesium sulfate exposure is independently associated with a decreased risk of MRI-detected cerebellar hemorrhage in premature newborns, which could explain some of the reported neuroprotective effects of magnesium sulfate.
Authors: Emily W Y Tam; Glenn Rosenbluth; Elizabeth E Rogers; Donna M Ferriero; David Glidden; Ruth B Goldstein; Hannah C Glass; Robert E Piecuch; A James Barkovich Journal: J Pediatr Date: 2010-09-15 Impact factor: 4.406
Authors: Shannon E G Hamrick; Steven P Miller; Carol Leonard; David V Glidden; Ruth Goldstein; Vijay Ramaswamy; Robert Piecuch; Donna M Ferriero Journal: J Pediatr Date: 2004-11 Impact factor: 4.406
Authors: Catherine Limperopoulos; Haim Bassan; Kimberlee Gauvreau; Richard L Robertson; Nancy R Sullivan; Carol B Benson; Lauren Avery; Jane Stewart; Janet S Soul; Steven A Ringer; Joseph J Volpe; Adré J duPlessis Journal: Pediatrics Date: 2007-09 Impact factor: 7.124
Authors: Deborah G Hirtz; Steven J Weiner; Dorothy Bulas; Michael DiPietro; Joanna Seibert; Dwight J Rouse; Brian M Mercer; Michael W Varner; Uma M Reddy; Jay D Iams; Ronald J Wapner; Yoram Sorokin; John M Thorp; Susan M Ramin; Fergal D Malone; Marshall W Carpenter; Mary J O'Sullivan; Alan M Peaceman; Gary D V Hankins; Donald Dudley; Steve N Caritis Journal: J Pediatr Date: 2015-08-05 Impact factor: 4.406
Authors: Dwight J Rouse; Deborah G Hirtz; Elizabeth Thom; Michael W Varner; Catherine Y Spong; Brian M Mercer; Jay D Iams; Ronald J Wapner; Yoram Sorokin; James M Alexander; Margaret Harper; John M Thorp; Susan M Ramin; Fergal D Malone; Marshall Carpenter; Menachem Miodovnik; Atef Moawad; Mary J O'Sullivan; Alan M Peaceman; Gary D V Hankins; Oded Langer; Steve N Caritis; James M Roberts Journal: N Engl J Med Date: 2008-08-28 Impact factor: 91.245
Authors: Erik van Tilborg; E J Marijke Achterberg; Caren M van Kammen; Annette van der Toorn; Floris Groenendaal; Rick M Dijkhuizen; Cobi J Heijnen; Louk J M J Vanderschuren; Manon N J L Benders; Cora H A Nijboer Journal: Glia Date: 2017-09-19 Impact factor: 7.452
Authors: Emily Shepherd; Rehana A Salam; Deepak Manhas; Anne Synnes; Philippa Middleton; Maria Makrides; Caroline A Crowther Journal: PLoS Med Date: 2019-12-06 Impact factor: 11.069